A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects

Clinical trial NCT06828120 · COMPLETED

Trial details

NCT number: NCT06828120
Sponsor: Bun Yao Biotechnology Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

COPD (Chronic Obstructive Pulmonary Disease)

Start date: 2025-02-20
Primary completion: 2025-09-03
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.